Log In Get Started
Press Releases August 5, 2026 09:34 AM

Stryker declares an $0.88 per share quarterly dividend

Stryker announces a 4.8% increase in quarterly dividend to $0.88 per share

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
SYK

Stryker Corporation declared a quarterly dividend of $0.88 per share, payable on July 31, 2026, to shareholders of record as of June 30, 2026. This represents a 4.8% increase compared to the prior year dividend rate and remains unchanged from the previous quarter. Stryker is a global leader in medical technologies, focusing on MedSurg, Neurotechnology, and Orthopaedics sectors, impacting over 150 million patients annually.

Stryker declares an $0.88 per share quarterly dividend
SYK
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Stryker increased its quarterly dividend by 4.8% compared to last year, signaling confidence in its financial health.
  • The dividend remains stable compared to the previous quarter, suggesting steady cash flow.
  • Stryker operates in the medical technologies sector with a broad impact on patient healthcare outcomes globally.

Portage, Michigan, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter. 

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

Contacts

For investor inquiries:
Nick Mead, Vice President, Investor Relations at 269-385-2600 or nick.mead@stryker.com   

For media inquiries:
Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or kim.montagnino@stryker.com


Risks

  • Dividend increases depend on continued strong financial performance, which could be affected by market conditions or operational risks.
  • Medical technology sector faces regulatory and innovation risks that could impact future profitability.
  • Global economic or healthcare funding changes may influence Stryker's revenue streams and dividend sustainability.

More from Press Releases

Axe Compute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Sep 11, 2026 EverCommerce Announces an Increase and Extension of its Share Repurchase Program Sep 11, 2026 Grupo Aeroportuario del Pacifico Announces the Execution of Bank Credit Facilities Totaling Ps. 8,000 Million Sep 11, 2026 Eastern International Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency Sep 11, 2026 ArrowMark Financial Corp. Announces Q2 Results and Special Distribution of $0.10 and Monthly Cash Distribution of $0.15 per Share for September 2026 Sep 11, 2026